Lower GI 2017

Meta-analysis - reduction in risk of disease recurrence (25%) with adjuvant chemotherapy compared to observation ( HR=0.75, CI: 0.68-0.83).

Only 1/21 trials received preoperative CRT Only 2/21 received SCPRT

Made with